Skip to main content

Hereditary Retinal Diseases: Stargardt, Choroideremia, Retinitis Pigmentosa

  • Chapter
  • First Online:
  • 380 Accesses

Abstract

Hereditary retinal diseases summarize a broad range of genetic disorders with different clinical manifestations. Depending on the genetic mutation, primarily the cones, the rods, or both types of photoreceptors are affected, determining the symptoms and signs of the affected patients.

In this chapter, results of FLIO findings in the most common hereditary retinal diseases including Stargardt disease, choroideremia, and retinitis pigmentosa are summarized.

Characteristic FLIO patterns are observed for every disease. In comparison to commonly used imaging techniques, FLIO provides additional information including evolution of flecks in Stargardt disease, and the integrity of photoreceptor layers in absence of the RPE in choroideremia and retinitis pigmentosa. Regarding early detection or retinal changes in hereditary retinal diseases as well as for diagnostic purposes and follow-up documentation also in the context of upcoming therapeutic interventions, FLIO might provide additional information in comparison to conventional imaging techniques.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Walia S, Fishman GA. Natural history of phenotypic changes in Stargardt macular dystrophy. Ophthalmic Genet. 2009;30(2):63–8.

    Article  Google Scholar 

  2. Haji Abdollahi S, Hirose T. Stargardt-Fundus flavimaculatus: recent advancements and treatment. Semin Ophthalmol. 2013;28(5–6):372–6.

    Article  Google Scholar 

  3. Koenekoop RK. The gene for Stargardt disease, ABCA4, is a major retinal gene: a mini-review. Ophthalmic Genet. 2003;24(2):75–80.

    Article  Google Scholar 

  4. Allikmets R, et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science. 1997;277(5333):1805–7.

    Article  CAS  Google Scholar 

  5. Allikmets R. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet. 1997;17(1):122.

    CAS  PubMed  Google Scholar 

  6. Smith RT, et al. Lipofuscin and autofluorescence metrics in progressive STGD. Invest Ophthalmol Vis Sci. 2009;50(8):3907–14.

    Article  Google Scholar 

  7. Cukras CA, et al. Centrifugal expansion of fundus autofluorescence patterns in Stargardt disease over time. Arch Ophthalmol. 2012;130(2):171–9.

    Article  Google Scholar 

  8. Gomes NL, et al. A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease. Invest Ophthalmol Vis Sci. 2009;50(8):3953–9.

    Article  Google Scholar 

  9. Armstrong JD, Xu S, Elfervig JL. Long-term follow-up of Stargardt's disease and fundus flavimaculatus. Ophthalmology. 1998;105:448–57.

    Article  CAS  Google Scholar 

  10. Rotenstreich Y, Fishman GA, Anderson RJ. Visual acuity loss and clinical observations in a large series of patients with Stargardt disease. Ophthalmology. 2003;110(6):1151–8.

    Article  Google Scholar 

  11. Fishman GA, et al. Variation of clinical expression in patients with Stargardt dystrophy and sequence variations in the ABCR gene. Arch Ophthalmol. 1999;117(4):504–10.

    Article  CAS  Google Scholar 

  12. Fishman GA, et al. Visual acuity loss in patients with Stargardt's macular dystrophy. Ophthalmology. 1987;94(7):809–14.

    Article  CAS  Google Scholar 

  13. Cornelis SS, et al. In Silico functional meta-analysis of 5,962 ABCA4 variants in 3,928 retinal dystrophy cases. Hum Mutat. 2017;38(4):400–8.

    Article  CAS  Google Scholar 

  14. Fishman GA. Fundus flavimaculatus. A clinical classification. Arch Ophthalmol. 1976;94(12):2061–7.

    Article  CAS  Google Scholar 

  15. Dysli C, et al. Fluorescence lifetime imaging in Stargardt disease: potential marker for disease progression. Invest Ophthalmol Vis Sci. 2016;57(3):832–41.

    Article  CAS  Google Scholar 

  16. Dysli C, et al. Quantitative analysis of fluorescence lifetime measurements of the macula using the fluorescence lifetime imaging ophthalmoscope in healthy subjects. Invest Ophthalmol Vis Sci. 2014;55(4):2106–13.

    Article  Google Scholar 

  17. Dysli C, et al. Fluorescence lifetime imaging ophthalmoscopy. Prog Retin Eye Res. 2017;60:120–43.

    Article  Google Scholar 

  18. Solberg Y, Dysli C, Escher P, Berger L, Wolf S, Zinkernagel MS. Retinal flecks in Stargardt Disease reveal characteristic fluorescence lifetime transition over time. Retina. 2019;39(5):1. https://doi.org/10.1097/IAE.0000000000002519.

    Article  Google Scholar 

  19. Sparrow JR, et al. Flecks in recessive Stargardt disease: short-wavelength autofluorescence, near-infrared autofluorescence, and optical coherence tomography. Invest Ophthalmol Vis Sci. 2015;56(8):5029–39.

    Article  Google Scholar 

  20. Liu J, et al. The biosynthesis of A2E, a fluorophore of aging retina, involves the formation of the precursor, A2-PE, in the photoreceptor outer segment membrane. J Biol Chem. 2000;275(38):29354–60.

    Article  CAS  Google Scholar 

  21. Dysli C, Wolf S, Zinkernagel MS. Autofluorescence lifetimes in geographic atrophy in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2016;57:2479–87. https://doi.org/10.1167/iovs.15-18381.

    Article  CAS  Google Scholar 

  22. Charbel Issa P, Barnard AR, Herrmann P, Washington I, MacLaren RE. Rescue of the Stargardt phenotype in Abca4 knockout mice through inhibition of vitamin A dimerization. Proc Natl Acad Sci U S A. 2015;112(27):8415–20.

    Article  Google Scholar 

  23. Campa C, et al. The role of gene therapy in the treatment of retinal diseases: a review. Curr Gene Ther. 2017;17(3):194–213.

    Article  CAS  Google Scholar 

  24. Zinkernagel MS, MacLaren RE. Recent advances and future prospects in choroideremia. Clin Ophthalmol. 2015;9:2195–200.

    Article  CAS  Google Scholar 

  25. Xue K, et al. Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia. Nat Med. 2018;24(10):1507–12.

    Article  Google Scholar 

  26. Dysli C, et al. Autofluorescence lifetimes in patients with choroideremia identify photoreceptors in areas with retinal pigment epithelium atrophy. Invest Ophthalmol Vis Sci. 2016;57(15):6714–21.

    Article  Google Scholar 

  27. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368(9549):1795–809.

    Article  CAS  Google Scholar 

  28. Shankar S. Hereditary retinal and choroidal dystrophies. In: Rimoin D, Pyeritz R, Korf B, editors. Emery and Rimoin’s principles and practice of medical genetics. London: Academic Press; 2013. p. 1–18. see also: https://www.elsevier.com/books/emery-and-rimoins-principles-and-practice-of-medical-genetics/rimoin/978-0-12-383834-6.

    Google Scholar 

  29. Ferrari S, et al. Retinitis pigmentosa: genes and disease mechanisms. Curr Genomics. 2011;12(4):238–49.

    Article  CAS  Google Scholar 

  30. Zhang Q. Retinitis pigmentosa: progress and perspective. Asia Pac J Ophthalmol (Phila). 2016;5(4):265–71.

    Article  CAS  Google Scholar 

  31. Daiger SP, Bowne SJ, Sullivan LS. Perspective on genes and mutations causing retinitis pigmentosa. Arch Ophthalmol. 2007;125(2):151–8.

    Article  CAS  Google Scholar 

  32. Fishman GA. Retinitis pigmentosa. Visual loss. Arch Ophthalmol. 1978;96(7):1185–8.

    Article  CAS  Google Scholar 

  33. Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis. 2006;1:40.

    Article  Google Scholar 

  34. Berson EL. Retinitis pigmentosa. The Friedenwald lecture. Invest Ophthalmol Vis Sci. 1993;34(5):1659–76.

    CAS  PubMed  Google Scholar 

  35. Murakami T, et al. Association between abnormal autofluorescence and photoreceptor disorganization in retinitis pigmentosa. Am J Ophthalmol. 2008;145(4):687–94.

    Article  Google Scholar 

  36. Andersen K, Sauer L, et al. Characterization of retinitis pigmentosa using Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO). Transl Vis Sci Technol. 2018;7:20.

    Article  Google Scholar 

  37. Dysli C, et al. Fundus autofluorescence lifetime patterns in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2018;59(5):1769–78.

    Article  CAS  Google Scholar 

  38. Lima LH, et al. Structural assessment of hyperautofluorescent ring in patients with retinitis pigmentosa. Retina. 2009;29(7):1025–31.

    Article  Google Scholar 

  39. Aizawa S, et al. Changes of fundus autofluorescence, photoreceptor inner and outer segment junction line, and visual function in patients with retinitis pigmentosa. Clin Exp Ophthalmol. 2010;38(6):597–604.

    Article  Google Scholar 

  40. Andersen KM, et al. Characterization of retinitis pigmentosa using Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO). Transl Vis Sci Technol. 2018;7(3):20.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chantal Dysli .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dysli, C., Solberg, Y., Sauer, L. (2019). Hereditary Retinal Diseases: Stargardt, Choroideremia, Retinitis Pigmentosa. In: Zinkernagel, M., Dysli, C. (eds) Fluorescence Lifetime Imaging Ophthalmoscopy. Springer, Cham. https://doi.org/10.1007/978-3-030-22878-1_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-22878-1_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-22877-4

  • Online ISBN: 978-3-030-22878-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics